Search

To curb the pandemic, the international community must take urgent steps to address unfair global access to vaccines. This requires transparency, accessible public information, and open public debate…

Payments and transfers between pharmaceuticals companies and healthcare professionals are common. These relationships can be positive, but regulation is needed to mediate them.

Corruption in the medical supply chain has been amplified by the Covid-19 pandemic. But this can help us identify ways to mitigate corruption in future health crises.

Anti-corruption interventions in the medical and pharmaceutical sectors in this region have consisted of promoting integrity, transparency and accountability, quality control testing and social…

Amplified by the Covid-19 pandemic, corruption impacts the quality of medical products. Anti-corruption approaches concentrate on prevention, detection, and response.

Experience from transparency initiatives for pharmaceutical policy in Colombia show that ‘radical’ transparency is necessary but not sufficient. A set of corruption prevention measures applied…

Diversifying manufacturing facilities in Africa will require a large-scale investment of resources – which brings significant corruption risks.